박사현 교수
1577-5587
전문진료분야
비뇨기종양(전립선, 방광, 신장, 고환, 부신), 로봇수술, 혈뇨, PSA 상승, 요로결석
전화 예약
1577-5587
기본정보
학력
2003.02 ~ 2009.02울산대학교 의학과 학사 졸업 2013.03 ~ 2018.02울산대학교 의학과 석사 졸업 2020.03 ~ 2022.02울산대학교 의학과 박사 졸업 |
경력
2009.03 ~ 2010.02서울아산병원 수련의 2010.03 ~ 2014.02서울아산병원 전공의 2017.05 ~ 2019.01서울아산병원 임상강사 2019.02 ~ 2020.09국립암센터 임상스텝전문의 2021.09 ~ 한림대학교강남성심병원 조교수 2021.09 ~ 한림대학교 의과대학 조교수 |
학회활동
대한비뇨의학회 대한비뇨기종양학회 대한전립선학회 |
수상이력
2012대한비뇨기종양학회 연제발표우수상 2017대한비뇨기종양학회 연제발표우수상 2020대한비뇨의학회 국외논문 기초 최우수상 |
논문
1. Pak S, Park SG, Kim JK, Lee SH, Lee WK, Oh CY, Woo JY, Cho ST, et al. Deep learning-based classification of acute scrotum using single ultrasound images. BJU Int. 2026;137(2):376-382.
2. Kim J, Park SG, Yoon J, Cho YS, Kym D, Hur J, Kwon O, Cho ST, Lee YG, et al. Lower urinary tract symptoms following perineal burns: Clinical characteristics and predictors of symptom persistence. Burns. 2025;107626.
3. Pak S, Park SG, Park J, Choi HR, Lee JH, Lee W, Cho ST, Lee YG, Ahn H. Application of deep learning for semantic segmentation in robotic prostatectomy: Comparison of convolutional neural networks and visual transformers. Investig Clin Urol. 2024;65(6):551.
4. Pak S, Park SG, Park J, Cho ST, Lee YG, Ahn H. Applications of artificial intelligence in urologic oncology. Investig Clin Urol. 2024;65(3):202.
5. Park SG, Park J, Choi HR, Lee JH, Cho ST, Lee YG, Ahn H, Pak S. Deep learning model for real-time semantic segmentation during intraoperative robotic prostatectomy. Eur Urol Open Sci. 2024;62:47-53.
6. Pak S, Suh J, Park SY, Kim Y, Cho YM, Ahn H. Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer. Front Oncol. 2022;12:972572.
7. Pak S, Jung KW, Park EH, Ko YH, Won YJ, Joung JY. Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer. Investig Clin Urol. 2022;63(2):175.
8. Pak S, Lee DE, You D, Jeong IG, Joung JY, Lee KH, Hong JH, Kim CS, et al. Validation of the European association of urology biochemical recurrence risk groups after radical prostatectomy in an Asian cohort and suggestions for refinement. Urol Oncol. 2021;39(5):298.e1-298.e6.
9. Pak S, Kim SY, Kim SH, Joung JY, Park WS, Chung J, Lee KH, Seo HK. Association between antibiotic treatment and the efficacy of intravesical BCG therapy in patients with high-risk non-muscle invasive bladder cancer. Front Oncol. 2021;11:570077.
10. Pak S, You D, Jeong IG, Lee DE, Kim SH, Joung JY, Lee KH, Hong JH, et al. Cause of mortality after radical prostatectomy and the impact of comorbidity in men with prostate cancer: a multi-institutional study in Korea. Cancer Res Treat. 2020.
11. Pak S, Suh YS, Lee DE, Kim SH, Joung JY, Park WS, Lee SJ, Lee KH. Association between postoperative detection of circulating tumor cells and recurrence in patients with prostate cancer. J Urol. 2020;203(6):1128-1134.
12. Pak S, Kim MS, Park EY, Kim SH, Lee KH, Joung JY. Association of body composition with survival and treatment efficacy in castration-resistant prostate cancer. Front Oncol. 2020;10:558.
13. Pak S, Lee D, You D, Jeong IG, Joung JY, Lee KH, Hong JH, Kim CS, et al. Validation of the European Association of Urology biochemical recurrence risk groups after radical prostatectomy in an Asian cohort and suggestions for refinement [abstract]. J Urol. 2020;203:e1137-e1138.
14. Joung JY, Pak S. Association of body composition with survival and efficacy of first-line treatment in patients with castration-resistant prostate cancer [abstract]. J Clin Oncol. 2020;38(6_suppl):115.
15. Kim H, Pak S, Park KJ, Kim M, Kim JK, Kim M, You D, Jeong IG, Song C, et al. Utility of multiparametric magnetic resonance imaging with PI-RADS, version 2, in patients with prostate cancer eligible for active surveillance. Clin Genitourin Cancer. 2020;18(1):50-55.
16. Pak S, You D, Jeong IG, Kim YS, Hong JH, Kim CS, Ahn H. Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer. Int J Clin Oncol. 2019;24(10):1238-1246.
17. Pak S, Kim W, Kim Y, Song C, Ahn H. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors. J Cancer Res Clin Oncol. 2019;145(9):2293-2301.
18. Pak S, Park SY, Shin TJ, You D, Jeong IG, Hong JH, Kim CS, Ahn H. Association of muscle mass with survival after radical prostatectomy in patients with prostate cancer. J Urol. 2019;202(3):525-532.
19. Pak S, Park S, Kim Y, Park JH, Park CH, Lee KJ, Kim C, Ahn H. The small molecule WNT/beta-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. J Exp Clin Cancer Res. 2019;38(1):342.
20. Pak S, You D, Jeong IG, Song C, Lee JL, Hong B, Hong JH, Kim CS, et al. Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer. Sci Rep. 2019;9(1):8305.
21. Pak S, You D, Jeong IG, Song C, Lee JL, Hong B, Hong JH, Kim CS, et al. Induction chemotherapy followed by surgery versus upfront radical cystectomy in patients with clinically node-positive muscle-invasive bladder cancer. Clin Genitourin Cancer. 2019;17(3):e420-e428.
22. Pak S, Ahn H. Changes in health-related quality of life after radical prostatectomy for prostate cancer: A longitudinal cohort study in Korea [reply]. Investig Clin Urol. 2019;60(3):224.
23. Pak S, Park S, Kim M, Go H, Cho YM, Ahn H. The impact on oncological outcomes after radical prostatectomy for prostate cancer of converting soft tissue margins at the apex and bladder neck from tumour-positive to-negative. BJU Int. 2019;123(5):811-817.
24. Pak S, Shin TJ, Kim H, Lee D, You D, Jeong IG, Song C, Lee JL, Hong B, et al. Adjuvant chemotherapy versus observation after radical cystectomy for patients with node-positive bladder cancer [abstract]. J Urol. 2019;201(Suppl 4):e451.
25. Kim H, Pak S, Kim M, Jeong IG, Song C, Hong JH, Kim CS, Ahn H. Is multiparametric MRI really helpful to predict upgrading and upstaging in active surveillance? Eur Urol Suppl. 2019;18(1):e1745.
26. Lee KJ. Correction to: The small molecule WNT/beta-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. J Exp Clin Cancer Res. 2019.
27. Pak S, Kim M, Ahn H. Changes in health-related quality of life after radical prostatectomy for prostate cancer: A longitudinal cohort study in Korea. Investig Clin Urol. 2018;59(5):313-320.
28. Pak S, Park S, Ryu J, Hong S, Song SH, You D, Jeong IG, Song C, et al. Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy. Korean J Urol. 2013;54(12):824-829.
29. Pak S, Park S, Song SH, You D, Song C, Ahn H. Characteristics of anterior predominant prostate cancer and the usefulness of multiparametric MRI in diagnosis [abstract]. 2013.
30. Kim J, Pak S, Shim M, Park J, Lee SM, Huh KO, Song C, Choo MS, Ahn H. Anticholinergics improved voiding symptom after radical prostatectomy in patients with prostate cancer [abstract]. Eur Urol Suppl. 2013;12(1):e1005.
31. Kim J, Pak S, Shim M, Park J, Song C, Ahn H. Preoperative sphincter function and morphology of prostate apex influence recovery of urinary continence after radical prostatectomy [abstract]. Eur Urol Suppl. 2013;12(1):e1010.
32. Kim SJ, Park SG, Pak S, Kwon O, Lee YG, Cho ST. Mediating effect of serum uric acid in the association between nocturia and mortality. Int Neurourol J. 2025;29(4):277.
33. Kim SJ, Park SG, Pak S, Kwon O, Lee YG, Cho ST. Metabolic syndrome and its components as independent risk factors for nocturia: A national cross-sectional analysis. Investig Clin Urol. 2025;67(1):52.
34. Kim SJ, Lee YG, Kwon O, Pak S, Park SG, Cho ST. Association of handgrip strength with urinary incontinence in postmenopausal Korean women: a machine learning study. Int Urogynecol J. 2025:1-9.
35. Cho ST, Kim SJ, Park SG, Pak S, Kwon O, Lee YG. Exploring the association between metabolic syndrome components and nocturia: A nationwide cohort analysis [abstract]. Eur Urol. 2025;87:S203.
36. Kim SJ, Park SG, Pak S, Lee YG, Cho ST. Association between urgency urinary incontinence and cause-specific mortality: a population-based analysis. World J Urol. 2024;43(1):22.
37. Kim SJ, Lee D, Park SG, Pak S, Lee YG, Cho ST. Reply to "Revisiting the nocturia-testosterone deficiency nexus: A circadian perspective." Neurourol Urodyn. 2024;43(4).
38. Kim SJ, Lee D, Park SG, Pak S, Lee YG, Cho ST. Benign prostatic hyperplasia and the risk of falls in older men: insights from a population-based study on geriatric morbid conditions. Int Neurourol J. 2024;28(1):44.
39. Kim S, Park SG, Lee DH, Pak S, Lee YG, Cho ST. The association between testosterone deficiency and nocturia in patients over 60 years with cardiovascular diseases [abstract]. Eur Urol. 2024;85:S2104-S2105.
40. Kim SJ, Lee D, Park SG, Pak S, Lee YG, Cho ST. The association between testosterone deficiency and nocturia: Insights from The National Health and Nutrition Examination Survey data set. Neurourol Urodyn. 2024;43(2):486-493.
41. Kim SJ, Park SG, Pak S, Kwon O, Lee YG, Cho ST. Predictive factors for postoperative medication therapy for overactive bladder symptoms after holmium laser enucleation of prostate. Int J Urol. 2023;30(11):1036-1043.
42. Kim SJ, Park II, Kim JW, Lee YG, Kwon O, Pak S, Park SG, Kim SJ. Decreased testosterone level is associated with nocturia in US men: A population-based cohort study [abstract]. J Urol. 2023;209(Suppl 4):e1072.
43. Cho S, Kim SJ, Park SG, Pak S, Kwon O, Lee YG. Predictive factors that continue to take medications for overactive bladder symptoms 3 months after holmium laser enucleation of prostate (HoLEP) [abstract]. Neurourol Urodyn. 2023;42:S114-S115.
44. Kim SJ, Park SG, Pak S, Lee YG, Cho ST, Kwon O. Predictive factors for alpha blocker use after transurethral prostatectomy: Can preoperative urodynamic outcome predict alpha blocker medication after surgery? PLoS One. 2022;17(9):e0274399.
45. Moon S, Kim YJ, Chung HS, Yu JM, Park II, Park SG, Pak S, Kwon O, et al. The relationship between nocturia and mortality: data from the National Health and Nutrition Examination Survey. Int Neurourol J. 2022;26(2):144.
46. Moon S, Kim YJ, Chung HS, Yu JM, Park II, Park SG, Pak S, Kwon O, et al. Nocturia as a Risk Factor for All-Cause and Cardiovascular Disease Mortality. 2021.
47. Lee HH, Park S, Joung JY, Kim SH. How does androgen deprivation therapy affect mental health including cognitive dysfunction in patients with prostate cancer? World J Mens Health. 2020;39(4):598.
48. Kim M, Park M, Pak S, Choi SK, Shim M, Song C, Ahn H. Integrity of the urethral sphincter complex, nerve-sparing, and long-term continence status after robotic-assisted radical prostatectomy. Eur Urol Focus. 2019;5(5):823-830.
49. Kim SH, Park WS, Park B, Pak S, Chung J. A retrospective analysis of the impact of metastasectomy on prognostic survival according to metastatic organs in patients with metastatic renal cell carcinoma. Front Oncol. 2019;9:413.
50. Song SH, Park S, Chae SY, Moon DH, Park S, Kim KS. Predictors of renal functional improvement after pyeloplasty in ureteropelvic junction obstruction: clinical value of visually assessed renal tissue tracer transit in 99mTc MAG3 diuretic renography. Urology. 2017;108:149-154.
51. Song SH, Pak S, Jeong IG, Kim KS, Park HK, Kim CS, Ahn H, Hong B. Outcomes of stent-change therapy for bilateral malignancy-related ureteral obstruction. Int Urol Nephrol. 2015;47(1):19-24.
52. Song SH, Pak S, Park S, Song C, Jeong IG, Choi HJ, Kim JK, Cho KS, et al. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging. J Urol. 2014;192(2):402-408.
53. Kwon T, Jeong IG, Pak S, You D, Song C, Hong JH, Ahn H, Kim CS. Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease. J Cancer Res Clin Oncol. 2014;140(7):1171-1177.
54. Park J, Yoo DS, Song C, Park S, Park S, Kim SC, Cho Y, Ahn H. Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience. World J Urol. 2014;32(1):193-199.
55. Ryu J, Pak S, Song M, Chun JY, Hong S, Choo MS. Elimination of Hunner's ulcers by fulguration in patients with interstitial cystitis: is it effective and long lasting? Korean J Urol. 2013;54(11):767-771.
56. Song SH, Pak S, Park S, Song C, Ahn H. Predictors of upgrading after radical prostatectomy in low-risk prostate cancer: role of MRI [abstract]. J Urol. 2013;189(4S):e551.
2. Kim J, Park SG, Yoon J, Cho YS, Kym D, Hur J, Kwon O, Cho ST, Lee YG, et al. Lower urinary tract symptoms following perineal burns: Clinical characteristics and predictors of symptom persistence. Burns. 2025;107626.
3. Pak S, Park SG, Park J, Choi HR, Lee JH, Lee W, Cho ST, Lee YG, Ahn H. Application of deep learning for semantic segmentation in robotic prostatectomy: Comparison of convolutional neural networks and visual transformers. Investig Clin Urol. 2024;65(6):551.
4. Pak S, Park SG, Park J, Cho ST, Lee YG, Ahn H. Applications of artificial intelligence in urologic oncology. Investig Clin Urol. 2024;65(3):202.
5. Park SG, Park J, Choi HR, Lee JH, Cho ST, Lee YG, Ahn H, Pak S. Deep learning model for real-time semantic segmentation during intraoperative robotic prostatectomy. Eur Urol Open Sci. 2024;62:47-53.
6. Pak S, Suh J, Park SY, Kim Y, Cho YM, Ahn H. Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer. Front Oncol. 2022;12:972572.
7. Pak S, Jung KW, Park EH, Ko YH, Won YJ, Joung JY. Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer. Investig Clin Urol. 2022;63(2):175.
8. Pak S, Lee DE, You D, Jeong IG, Joung JY, Lee KH, Hong JH, Kim CS, et al. Validation of the European association of urology biochemical recurrence risk groups after radical prostatectomy in an Asian cohort and suggestions for refinement. Urol Oncol. 2021;39(5):298.e1-298.e6.
9. Pak S, Kim SY, Kim SH, Joung JY, Park WS, Chung J, Lee KH, Seo HK. Association between antibiotic treatment and the efficacy of intravesical BCG therapy in patients with high-risk non-muscle invasive bladder cancer. Front Oncol. 2021;11:570077.
10. Pak S, You D, Jeong IG, Lee DE, Kim SH, Joung JY, Lee KH, Hong JH, et al. Cause of mortality after radical prostatectomy and the impact of comorbidity in men with prostate cancer: a multi-institutional study in Korea. Cancer Res Treat. 2020.
11. Pak S, Suh YS, Lee DE, Kim SH, Joung JY, Park WS, Lee SJ, Lee KH. Association between postoperative detection of circulating tumor cells and recurrence in patients with prostate cancer. J Urol. 2020;203(6):1128-1134.
12. Pak S, Kim MS, Park EY, Kim SH, Lee KH, Joung JY. Association of body composition with survival and treatment efficacy in castration-resistant prostate cancer. Front Oncol. 2020;10:558.
13. Pak S, Lee D, You D, Jeong IG, Joung JY, Lee KH, Hong JH, Kim CS, et al. Validation of the European Association of Urology biochemical recurrence risk groups after radical prostatectomy in an Asian cohort and suggestions for refinement [abstract]. J Urol. 2020;203:e1137-e1138.
14. Joung JY, Pak S. Association of body composition with survival and efficacy of first-line treatment in patients with castration-resistant prostate cancer [abstract]. J Clin Oncol. 2020;38(6_suppl):115.
15. Kim H, Pak S, Park KJ, Kim M, Kim JK, Kim M, You D, Jeong IG, Song C, et al. Utility of multiparametric magnetic resonance imaging with PI-RADS, version 2, in patients with prostate cancer eligible for active surveillance. Clin Genitourin Cancer. 2020;18(1):50-55.
16. Pak S, You D, Jeong IG, Kim YS, Hong JH, Kim CS, Ahn H. Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer. Int J Clin Oncol. 2019;24(10):1238-1246.
17. Pak S, Kim W, Kim Y, Song C, Ahn H. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors. J Cancer Res Clin Oncol. 2019;145(9):2293-2301.
18. Pak S, Park SY, Shin TJ, You D, Jeong IG, Hong JH, Kim CS, Ahn H. Association of muscle mass with survival after radical prostatectomy in patients with prostate cancer. J Urol. 2019;202(3):525-532.
19. Pak S, Park S, Kim Y, Park JH, Park CH, Lee KJ, Kim C, Ahn H. The small molecule WNT/beta-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. J Exp Clin Cancer Res. 2019;38(1):342.
20. Pak S, You D, Jeong IG, Song C, Lee JL, Hong B, Hong JH, Kim CS, et al. Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer. Sci Rep. 2019;9(1):8305.
21. Pak S, You D, Jeong IG, Song C, Lee JL, Hong B, Hong JH, Kim CS, et al. Induction chemotherapy followed by surgery versus upfront radical cystectomy in patients with clinically node-positive muscle-invasive bladder cancer. Clin Genitourin Cancer. 2019;17(3):e420-e428.
22. Pak S, Ahn H. Changes in health-related quality of life after radical prostatectomy for prostate cancer: A longitudinal cohort study in Korea [reply]. Investig Clin Urol. 2019;60(3):224.
23. Pak S, Park S, Kim M, Go H, Cho YM, Ahn H. The impact on oncological outcomes after radical prostatectomy for prostate cancer of converting soft tissue margins at the apex and bladder neck from tumour-positive to-negative. BJU Int. 2019;123(5):811-817.
24. Pak S, Shin TJ, Kim H, Lee D, You D, Jeong IG, Song C, Lee JL, Hong B, et al. Adjuvant chemotherapy versus observation after radical cystectomy for patients with node-positive bladder cancer [abstract]. J Urol. 2019;201(Suppl 4):e451.
25. Kim H, Pak S, Kim M, Jeong IG, Song C, Hong JH, Kim CS, Ahn H. Is multiparametric MRI really helpful to predict upgrading and upstaging in active surveillance? Eur Urol Suppl. 2019;18(1):e1745.
26. Lee KJ. Correction to: The small molecule WNT/beta-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. J Exp Clin Cancer Res. 2019.
27. Pak S, Kim M, Ahn H. Changes in health-related quality of life after radical prostatectomy for prostate cancer: A longitudinal cohort study in Korea. Investig Clin Urol. 2018;59(5):313-320.
28. Pak S, Park S, Ryu J, Hong S, Song SH, You D, Jeong IG, Song C, et al. Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy. Korean J Urol. 2013;54(12):824-829.
29. Pak S, Park S, Song SH, You D, Song C, Ahn H. Characteristics of anterior predominant prostate cancer and the usefulness of multiparametric MRI in diagnosis [abstract]. 2013.
30. Kim J, Pak S, Shim M, Park J, Lee SM, Huh KO, Song C, Choo MS, Ahn H. Anticholinergics improved voiding symptom after radical prostatectomy in patients with prostate cancer [abstract]. Eur Urol Suppl. 2013;12(1):e1005.
31. Kim J, Pak S, Shim M, Park J, Song C, Ahn H. Preoperative sphincter function and morphology of prostate apex influence recovery of urinary continence after radical prostatectomy [abstract]. Eur Urol Suppl. 2013;12(1):e1010.
32. Kim SJ, Park SG, Pak S, Kwon O, Lee YG, Cho ST. Mediating effect of serum uric acid in the association between nocturia and mortality. Int Neurourol J. 2025;29(4):277.
33. Kim SJ, Park SG, Pak S, Kwon O, Lee YG, Cho ST. Metabolic syndrome and its components as independent risk factors for nocturia: A national cross-sectional analysis. Investig Clin Urol. 2025;67(1):52.
34. Kim SJ, Lee YG, Kwon O, Pak S, Park SG, Cho ST. Association of handgrip strength with urinary incontinence in postmenopausal Korean women: a machine learning study. Int Urogynecol J. 2025:1-9.
35. Cho ST, Kim SJ, Park SG, Pak S, Kwon O, Lee YG. Exploring the association between metabolic syndrome components and nocturia: A nationwide cohort analysis [abstract]. Eur Urol. 2025;87:S203.
36. Kim SJ, Park SG, Pak S, Lee YG, Cho ST. Association between urgency urinary incontinence and cause-specific mortality: a population-based analysis. World J Urol. 2024;43(1):22.
37. Kim SJ, Lee D, Park SG, Pak S, Lee YG, Cho ST. Reply to "Revisiting the nocturia-testosterone deficiency nexus: A circadian perspective." Neurourol Urodyn. 2024;43(4).
38. Kim SJ, Lee D, Park SG, Pak S, Lee YG, Cho ST. Benign prostatic hyperplasia and the risk of falls in older men: insights from a population-based study on geriatric morbid conditions. Int Neurourol J. 2024;28(1):44.
39. Kim S, Park SG, Lee DH, Pak S, Lee YG, Cho ST. The association between testosterone deficiency and nocturia in patients over 60 years with cardiovascular diseases [abstract]. Eur Urol. 2024;85:S2104-S2105.
40. Kim SJ, Lee D, Park SG, Pak S, Lee YG, Cho ST. The association between testosterone deficiency and nocturia: Insights from The National Health and Nutrition Examination Survey data set. Neurourol Urodyn. 2024;43(2):486-493.
41. Kim SJ, Park SG, Pak S, Kwon O, Lee YG, Cho ST. Predictive factors for postoperative medication therapy for overactive bladder symptoms after holmium laser enucleation of prostate. Int J Urol. 2023;30(11):1036-1043.
42. Kim SJ, Park II, Kim JW, Lee YG, Kwon O, Pak S, Park SG, Kim SJ. Decreased testosterone level is associated with nocturia in US men: A population-based cohort study [abstract]. J Urol. 2023;209(Suppl 4):e1072.
43. Cho S, Kim SJ, Park SG, Pak S, Kwon O, Lee YG. Predictive factors that continue to take medications for overactive bladder symptoms 3 months after holmium laser enucleation of prostate (HoLEP) [abstract]. Neurourol Urodyn. 2023;42:S114-S115.
44. Kim SJ, Park SG, Pak S, Lee YG, Cho ST, Kwon O. Predictive factors for alpha blocker use after transurethral prostatectomy: Can preoperative urodynamic outcome predict alpha blocker medication after surgery? PLoS One. 2022;17(9):e0274399.
45. Moon S, Kim YJ, Chung HS, Yu JM, Park II, Park SG, Pak S, Kwon O, et al. The relationship between nocturia and mortality: data from the National Health and Nutrition Examination Survey. Int Neurourol J. 2022;26(2):144.
46. Moon S, Kim YJ, Chung HS, Yu JM, Park II, Park SG, Pak S, Kwon O, et al. Nocturia as a Risk Factor for All-Cause and Cardiovascular Disease Mortality. 2021.
47. Lee HH, Park S, Joung JY, Kim SH. How does androgen deprivation therapy affect mental health including cognitive dysfunction in patients with prostate cancer? World J Mens Health. 2020;39(4):598.
48. Kim M, Park M, Pak S, Choi SK, Shim M, Song C, Ahn H. Integrity of the urethral sphincter complex, nerve-sparing, and long-term continence status after robotic-assisted radical prostatectomy. Eur Urol Focus. 2019;5(5):823-830.
49. Kim SH, Park WS, Park B, Pak S, Chung J. A retrospective analysis of the impact of metastasectomy on prognostic survival according to metastatic organs in patients with metastatic renal cell carcinoma. Front Oncol. 2019;9:413.
50. Song SH, Park S, Chae SY, Moon DH, Park S, Kim KS. Predictors of renal functional improvement after pyeloplasty in ureteropelvic junction obstruction: clinical value of visually assessed renal tissue tracer transit in 99mTc MAG3 diuretic renography. Urology. 2017;108:149-154.
51. Song SH, Pak S, Jeong IG, Kim KS, Park HK, Kim CS, Ahn H, Hong B. Outcomes of stent-change therapy for bilateral malignancy-related ureteral obstruction. Int Urol Nephrol. 2015;47(1):19-24.
52. Song SH, Pak S, Park S, Song C, Jeong IG, Choi HJ, Kim JK, Cho KS, et al. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging. J Urol. 2014;192(2):402-408.
53. Kwon T, Jeong IG, Pak S, You D, Song C, Hong JH, Ahn H, Kim CS. Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease. J Cancer Res Clin Oncol. 2014;140(7):1171-1177.
54. Park J, Yoo DS, Song C, Park S, Park S, Kim SC, Cho Y, Ahn H. Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience. World J Urol. 2014;32(1):193-199.
55. Ryu J, Pak S, Song M, Chun JY, Hong S, Choo MS. Elimination of Hunner's ulcers by fulguration in patients with interstitial cystitis: is it effective and long lasting? Korean J Urol. 2013;54(11):767-771.
56. Song SH, Pak S, Park S, Song C, Ahn H. Predictors of upgrading after radical prostatectomy in low-risk prostate cancer: role of MRI [abstract]. J Urol. 2013;189(4S):e551.